Medical Genetics in Ophthalmology: Through the Lens of Genetics-Informed Therapies OnDemand-Welcome and Specialist Language Barriers: What Is the Eye Doctor Saying?

Welcome and Specialist Language Barriers: What Is the Eye Doctor Saying?

Video Transcription

Video Summary

The speaker highlights the availability of effective low vision rehabilitation in some countries, emphasizing the need to guide patients to these services, which remain scarce globally. Gene-based therapies, proven effective especially when applied early, are advancing, as demonstrated by RPE65 trials. Vision enhancement technology is improving patient functionality significantly. Prenatal diagnosis is also accessible and utilized. Overall, ophthalmic genetics is thriving, with ongoing advancements benefiting patients. The speaker expresses gratitude to colleagues and the host for contributing to the field's progress.

Asset Subtitle

Elias I. Traboulsi, MD, MEd

We apologize that approximately the first 15 minutes of the opening session and the beginning of Dr. Elias I. Traboulsi’s presentation are currently unavailable. We are actively working to correct this issue and expect it to be resolved by the end of April.

We appreciate your patience and apologize for any inconvenience.

Keywords

low vision rehabilitation

gene-based therapies

RPE65 trials

vision enhancement technology

ophthalmic genetics